National Institutes of Health classification for chronic graft-versus-host disease predicts outcome of allo-hematopoietic stem cell transplant after fludarabine–busulfan–antithymocyte globulin conditioning regimen-Reference-Cited by-同舟云学术

National Institutes of Health classification for chronic graft-versus-host disease predicts outcome of allo-hematopoietic stem cell transplant after fludarabine–busulfan–antithymocyte globulin conditioning regimen

Published:2014-02-04 Issue:5 Volume:55 Page:1106-1112
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Saillard Colombe,Crocchiolo Roberto,Furst Sabine,El-Cheikh Jean,Castagna Luca,Signori Alessio,Oudin Claire,Faucher Catherine,Lemarie Claude,Chabannon Christian,Granata Angela,Blaise Didier

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2013.820285

Reference45 articles.

1. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group Report

2. Chronic graft-versus-host disease

3. Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia [published erratum appears in Blood 1989 Aug 15;74(3):1180]

4. Antileukemic Effect of Chronic Graft-versus-Host Disease

5. Chronic graft-versus-host syndrome in man

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Graft Versus Host Disease: Management Issues in the Intensive Care Unit;Journal of Intensive Care Medicine;2024-08-07

2. Propensity Score Matching Analysis Comparing the Efficacy and Steroid Tapering Benefit of Extracorporeal Photopheresis to Best Available Therapy in Third-Line or Beyond Treatment for Chronic GvHD;Transplantation and Cellular Therapy;2023-12

3. Propensity score matching analysis comparing the efficacy of Ruxolitinib to historical controls in second-line or beyond treatment for chronic GvHD after steroid failure;Bone Marrow Transplantation;2023-06-26

4. Population-based real-world registry study to evaluate clinical outcomes of chronic graft-versus-host disease;PLOS ONE;2023-03-09

5. Preemptive interferon-α therapy could prevent relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: A real-world analysis;Frontiers in Immunology;2023-02-02